Literature DB >> 21512163

Consequences of epidermal growth factor receptor (ErbB1) loss for vascular smooth muscle cells from mice with targeted deletion of ErbB1.

Barbara Schreier1, Maria Döhler, Sindy Rabe, Bettina Schneider, Gerald Schwerdt, Stefanie Ruhs, Maria Sibilia, Michael Gotthardt, Michael Gekle, Claudia Grossmann.   

Abstract

OBJECTIVE: Pathophysiological effects of the epidermal growth factor receptor (EGFR or ErbB1) include vascular remodeling. EGFR transactivation is proposed to contribute significantly to heterologous signaling and remodeling in vascular smooth muscle cells (VSMC). METHODS AND
RESULTS: We investigated the importance of EGFR in primary VSMC from aorta of mice with targeted deletion of the EGFR (EGFR(Δ/Δ VSMC)→VSMC(EGFR-/-) and EGFR(Δ/+ VSMC)→VSMC(EGFR+/-)) and the respective littermate controls (EGFR(+/+ VSMC)→VSMC(EGFR+/+)) with respect to survival, pentose phosphate pathway activity, matrix homeostasis, extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation, and Ca(2+) homeostasis. In VSMC(EGFR-/-), epidermal growth factor-induced signaling was abolished; VSMC(EGFR+/-) showed an intermediate phenotype. EGFR deletion enhanced spontaneous cell death, reduced pentose phosphate pathway activity, disturbed cellular matrix homeostasis (collagen III and fibronectin), and abolished epidermal growth factor sensitivity. In VSMC(EGFR-/-) endothelin-1- or α(1)-adrenoceptor-induced ERK1/2 phosphorylation and the fraction of Ca(2+) responders were significantly reduced, whereas responsive cells showed a significantly stronger Ca(2+) signal. Oxidative stress (H(2)O(2)) induced ERK1/2 activation in VSMC(EGFR+/+) and VSMC(EGFR+/-) but not in VSMC(EGFR-/-). The Ca(2+) signal was enhanced in VSMC(EGFR-/-), similar to purinergic stimulation by ATP.
CONCLUSIONS: In conclusion, EGFR was found to be important for basal VSMC homeostasis and ERK1/2 activation by the tested G-protein-coupled receptors or radical stress. Ca(2+) signaling was modulated by EGFR differentially with respect to the fraction of responders and magnitude of the signal. Thus, EGFR seems to be Janus-faced for VSMC biology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21512163     DOI: 10.1161/ATVBAHA.111.223537

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  18 in total

Review 1.  The roles of integrins in mediating the effects of mechanical force and growth factors on blood vessels in hypertension.

Authors:  Jun-Tzu Chao; Michael J Davis
Journal:  Curr Hypertens Rep       Date:  2011-12       Impact factor: 5.369

Review 2.  Novel tyrosine kinase signaling pathways: implications in vascular remodeling.

Authors:  Sri N Batchu; Vyacheslav A Korshunov
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-03       Impact factor: 2.894

Review 3.  Cardiovascular Risks with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Monoclonal Antibody Therapy.

Authors:  Kalyan R Chitturi; Ethan A Burns; Ibrahim N Muhsen; Kartik Anand; Barry H Trachtenberg
Journal:  Curr Oncol Rep       Date:  2022-02-22       Impact factor: 5.075

4.  The Functional Interaction of EGFR with AT1R or TP in Primary Vascular Smooth Muscle Cells Triggers a Synergistic Regulation of Gene Expression.

Authors:  Virginie Dubourg; Barbara Schreier; Gerald Schwerdt; Sindy Rabe; Ralf A Benndorf; Michael Gekle
Journal:  Cells       Date:  2022-06-16       Impact factor: 7.666

5.  Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System.

Authors:  Steven J Forrester; Tatsuo Kawai; Shannon O'Brien; Walter Thomas; Raymond C Harris; Satoru Eguchi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-11-09       Impact factor: 13.820

6.  Transcription-independent Induction of ERBB1 through Hypoxia-inducible Factor 2A Provides Cardioprotection during Ischemia and Reperfusion.

Authors:  Jae W Lee; Michael Koeppen; Seong-Wook Seo; Jessica L Bowser; Xiaoyi Yuan; Jiwen Li; Maria Sibilia; Amrut V Ambardekar; Xu Zhang; Tobias Eckle; Seung-Hee Yoo; Holger K Eltzschig
Journal:  Anesthesiology       Date:  2020-04       Impact factor: 7.892

7.  Mineralocorticoid receptor interaction with SP1 generates a new response element for pathophysiologically relevant gene expression.

Authors:  Sandra Meinel; Stefanie Ruhs; Katja Schumann; Nicole Strätz; Kay Trenkmann; Barbara Schreier; Ivo Grosse; Jens Keilwagen; Michael Gekle; Claudia Grossmann
Journal:  Nucleic Acids Res       Date:  2013-07-01       Impact factor: 16.971

8.  Mig-6 gene knockout induces neointimal hyperplasia in the vascular smooth muscle cell.

Authors:  Ju Hee Lee; Sorim Choung; Ji Min Kim; Jung Uee Lee; Koon Soon Kim; Hyun Jin Kim; Jae-Wook Jeong; Bon Jeong Ku
Journal:  Dis Markers       Date:  2014-12-10       Impact factor: 3.434

9.  Moderate inappropriately high aldosterone/NaCl constellation in mice: cardiovascular effects and the role of cardiovascular epidermal growth factor receptor.

Authors:  Barbara Schreier; Sindy Rabe; Sabrina Winter; Stefanie Ruhs; Sigrid Mildenberger; Bettina Schneider; Maria Sibilia; Michael Gotthardt; Sabine Kempe; Karsten Mäder; Claudia Grossmann; Michael Gekle
Journal:  Sci Rep       Date:  2014-12-11       Impact factor: 4.379

Review 10.  The epidermal growth factor receptor and its ligands in cardiovascular disease.

Authors:  Nader Makki; Kristina W Thiel; Francis J Miller
Journal:  Int J Mol Sci       Date:  2013-10-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.